{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-angiogenic", "cytotoxicity", "pro-apoptotic"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28367666", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "05"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/13880209.2017.1307422"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "55", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.", "Pagination": {"StartPage": "1489", "EndPage": "1499", "MedlinePgn": "1489-1499"}, "Abstract": {"AbstractText": ["Abnormal angiogenesis and evasion of apoptosis are hallmarks of cancer. Accordingly, anti-angiogenic and pro-apoptotic therapies are effective strategies for cancer treatment. Medicinal plants, namely, Eugenia jambolana Lam. (Myrtaceae), Musa paradisiaca L. (Musaceae), and Coccinia indica Wight & Arn. (Cucurbitaceae), have not been greatly investigated for their anticancer potential.", "We investigated the anti-angiogenic and pro-apoptotic efficacy of ethyl acetate (EA) and n-butanol (NB) extracts of E. jambolana (seeds), EA extracts of M. paradisiaca (roots) and C. indica (leaves) with respect to mammary neoplasia.", "Effect of extracts (2-200\u2009\u03bcg/mL) on cytotoxicity and MCF-7, MDA-MB-231 and endothelial cell (EC) proliferation and in vitro angiogenesis were evaluated by MTT, <sup>3</sup>[H]thymidine uptake and EC tube formation assays, respectively. In vivo tumour proliferation, VEGF secretion and angiogenesis were assessed using the Ehrlich ascites tumour (EAT) model followed by rat corneal micro-pocket and chicken chorioallantoic membrane (CAM) assays. Apoptosis induction was assessed by morphological and cell cycle analysis.", "EA extracts of E. jambolana and M. paradisiaca exhibited the highest cytotoxicity (IC<sub>50</sub> 25 and 60\u2009\u03bcg/mL), inhibited cell proliferation (up to 81%), and tube formation (83% and 76%). In vivo treatment reduced body weight (50%); cell number (16.5- and 14.7-fold), secreted VEGF (\u223c90%), neoangiogenesis in rat cornea (2.5- and 1.5-fold) and CAM (3- and 1.6-fold) besides EAT cells accumulation in sub-G1 phase (20% and 18.38%), respectively.", "Considering the potent anti-angiogenic and pro-apoptotic properties, lead molecules from EA extracts of E. jambolana and M. paradisiaca can be developed into anticancer drugs."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Studies in Biotechnology , Molecular Oncology Lab, University of Mysore , Mysore , India."}], "LastName": "M", "ForeName": "Harsha Raj", "Initials": "HR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of Bio-Medical Laboratory Science & Management , Vidyasagar University , Midnapore , West Bengal , India."}], "LastName": "Ghosh", "ForeName": "Debidas", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Department of Science & Technology , Government of India , New Delhi , India."}], "LastName": "Banerjee", "ForeName": "Rita", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a Department of Studies in Biotechnology , Molecular Oncology Lab, University of Mysore , Mysore , India."}], "LastName": "Salimath", "ForeName": "Bharathi P", "Initials": "BP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Acetates"}, {"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "VEGFA protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Vascular Endothelial Growth Factor A"}, {"RegistryNumber": "76845O8NMZ", "NameOfSubstance": "ethyl acetate"}, {"RegistryNumber": "8PJ61P6TS3", "NameOfSubstance": "1-Butanol"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "1-Butanol"}, {"QualifierName": ["chemistry"], "DescriptorName": "Acetates"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["blood", "pathology", "prevention & control"], "DescriptorName": "Carcinoma, Ehrlich Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Movement"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "Chick Embryo"}, {"QualifierName": ["blood supply"], "DescriptorName": "Chorioallantoic Membrane"}, {"QualifierName": ["pathology", "physiopathology", "prevention & control"], "DescriptorName": "Corneal Neovascularization"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cucurbitaceae"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "G1 Phase Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Human Umbilical Vein Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "MCF-7 Cells"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["chemistry"], "DescriptorName": "Musa"}, {"QualifierName": [], "DescriptorName": "Neovascularization, Pathologic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Neovascularization, Physiologic"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plant Leaves"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Roots"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["chemistry"], "DescriptorName": "Seeds"}, {"QualifierName": ["chemistry"], "DescriptorName": "Syzygium"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Burden"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Vascular Endothelial Growth Factor A"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Afsar T, Trembley JH, Salomon CE, Razak S, Khan MR, Ahmed K.. 2016. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: involvement of multiple signal transduction pathways. Sci Rep. 6:23077.", "ArticleIdList": ["PMC4791679", "26975752"]}, {"Citation": "Ali EM, Sheta M, El Mohsen MA.. 2011. Elevated serum and tissue VEGF associated with poor outcome in breast cancer patients. Alexandria J Med. 47:217\u2013224."}, {"Citation": "Andzi-Barh\u00e9 T, Massala KK, Obame LC, Engonga JL.. 2015. Phytochemical studies, total phenolic and flavonoids content and evaluation of antiradical activity of the extracts of the leaves from Dischistocalyx sp. (Acanthaceae). J Pharmacogn Phytochem. 3:174\u2013178."}, {"Citation": "Baliga MS.2011. Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana Lam.). Asian Pac J Cancer Prev. 12:3\u201315.", "ArticleIdList": ["21517226"]}, {"Citation": "Bikfalvi A, Bicknell R.. 2002. Recent advances in angiogenesis, anti-angiogenesis and vascular targeting. Trends Pharmacol Sci. 23:576\u2013582.", "ArticleIdList": ["12457776"]}, {"Citation": "Carbajo-Pescador S, Ordonez R, Benet M, Jover R, Garc\u00eda-Palomo A, Mauriz JL, Gonz\u00e1lez-Gallego J.. 2013. Inhibition of VEGF expression through blockade of Hif1\u03b1 and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer. 109:83\u201391.", "ArticleIdList": ["PMC3708553", "23756865"]}, {"Citation": "Carmeliet P, Jain RK.. 2011. Molecular mechanisms and clinical applications of angiogenesis. Nature. 473:298\u2013307.", "ArticleIdList": ["PMC4049445", "21593862"]}, {"Citation": "Chatterjee K, Ali KM, Ghosh D.. 2009. Antihyperglycaemic, antioxidative activities of a formulated polyherbal drug MTEC (Modified) in streptozotocin-induced diabetic rat. J Med Plant Res. 3:468\u2013480."}, {"Citation": "Claesson-Welsh L, Welsh M.. 2013. VEGFA and tumor angiogenesis. J Intern Med. 273:14\u2013127.", "ArticleIdList": ["23216836"]}, {"Citation": "Dent SF.2009. The role of VEGF in triple-negative breast cancer: where do we go from here? Ann Oncol. 20:1615\u20131617.", "ArticleIdList": ["19690059"]}, {"Citation": "Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, Dou HL, Pines M, Vlodavsky I.. 2000. Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 14:2477\u20132485.", "ArticleIdList": ["11099465"]}, {"Citation": "Eun JP, Koh GY.. 2004. Suppression of angiogenesis by the plant alkaloid, sanguinarine. Biochem Biophys Res Commun. 317:618\u2013624.", "ArticleIdList": ["15063803"]}, {"Citation": "Fan TP, Yeh JC, Leung KW, Yue PY, Wong RN.. 2006. Angiogenesis: from plants to blood vessels. Trends Pharmacol Sci. 27:297\u2013309.", "ArticleIdList": ["16697473"]}, {"Citation": "Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F.. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:359\u2013386.", "ArticleIdList": ["25220842"]}, {"Citation": "Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A, Maulik N.. 2006. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys. 44:43\u201349.", "ArticleIdList": ["16456233"]}, {"Citation": "Ghosh D.2015. In vitro antioxidant potential of ethyl acetate fraction of seed of Eugenia jambolana. Asian J Pharm Clin Res. 8:167\u2013170."}, {"Citation": "Goel HL, Mercurio AM.. 2013. VEGF targets the tumour cell. Nat Rev Cancer. 13:871\u2013882.", "ArticleIdList": ["PMC4011842", "24263190"]}, {"Citation": "Gordaliza M.2007. Natural products as leads to anticancer drugs. Clin Transl Oncol. 9:767\u2013776.", "ArticleIdList": ["18158980"]}, {"Citation": "Guo C, Buranych A, Sarkar D, Fisher PB, Wang XY.. 2013. The role of tumor-associated macrophages in tumor vascularization. Vasc Cell. 5:1\u201320.", "ArticleIdList": ["PMC3913793", "24314323"]}, {"Citation": "Gururaj AE, Belakavadi M, Venkatesh DA, Marm\u00e9 D, Salimath BP.. 2002. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. 97:934\u2013942.", "ArticleIdList": ["12359244"]}, {"Citation": "Hojjat-Farsangi M.2014. Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies. Int J Mol Sci. 15:13768\u201313801.", "ArticleIdList": ["PMC4159824", "25110867"]}, {"Citation": "Lee JS, Shukla S, Kim JA, Kim M.. 2015. Anti-angiogenic effect of Nelumbo nucifera leaf extracts in human umbilical vein endothelial cells with antioxidant potential. PLoS One. 10:e0118552.", "ArticleIdList": ["PMC4340789", "25714482"]}, {"Citation": "Lingaraju SM, Keshavaiah K, Salimath BP.. 2008. Inhibition of in vivo angiogenesis by Anacardium occidentale L. involves repression of the cytokine VEGF gene expression. Drug Discov Ther. 2:234\u2013244.", "ArticleIdList": ["22504635"]}, {"Citation": "Loboda A, Jazwa A, Wegiel B, Jozkowicz A, Dulak J.. 2005. Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells. Cell Mol Biol. 51:347.", "ArticleIdList": ["PMC1403815", "16309584"]}, {"Citation": "Lu K, Bhat M, Basu S.. 2016. Plants and their active compounds: natural molecules to target angiogenesis. Angiogenesis. 19:287\u2013295.", "ArticleIdList": ["PMC4930694", "27154020"]}, {"Citation": "Mallick C, De D, Ghosh D.. 2009. Correction of protein metabolic disorders by composite extract of Musa paradisiaca and Coccinia indica in streptozotocin-induced diabetic albino rat: an approach through the pancreas. Pancreas. 38:322\u2013329.", "ArticleIdList": ["19169172"]}, {"Citation": "Mallick C, Maiti R, Ghosh D.. 2006. Antidiabetogenic effects of separate and composite extract of seed of Jamun (Eugenia jambolana) and root of Kadali (Musa paradisiaca) in streptozotocin-induced diabetic male albino rat: a comparative study. Int J Pharmacol. 2:492\u2013503."}, {"Citation": "Miao S, Shi X, Zhang H, Wang S, Sun J, Hua W, Miao Q, Zhao Y, Zhang C.. 2011. Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia K562 cell line in vitro. Int J Mol Sci. 12:3831\u20133845.", "ArticleIdList": ["PMC3131594", "21747710"]}, {"Citation": "Miller KD, Rahman ZU, Sledge Jr GW.. 2001. Selection bias in clinical trials. Breast Dis. 14:31\u201340.", "ArticleIdList": ["15687634"]}, {"Citation": "Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH, Kim KW, Gho YS, Kwon YG.. 2004. Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res. 64:644\u2013651.", "ArticleIdList": ["14744780"]}, {"Citation": "Nadumane VK, Timsina B.. 2014. Anti-cancer potential of banana flower extract: an in vitro study. Bangladesh J. Pharmacol. 9:628\u2013635."}, {"Citation": "Nagaraj SRM, Shilpa P, Rachaiah K, Salimath BP.. 2015. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma. Mol Carcinog. 54:333\u2013350.", "ArticleIdList": ["24265228"]}, {"Citation": "Nataraj NB, Salimath BP.. 2013. Crosstalk between VEGF and novel angiogenic protein regulates tumor angiogenesis and contributes to aggressiveness of breast carcinoma. Cell Signal. 25:277\u2013294.", "ArticleIdList": ["23000338"]}, {"Citation": "Neal C, Berry D, Doucas H, Manson M, Steward W, Garcea G.. 2006. Clinical aspects of natural anti-angiogenic drugs. Curr Drug Targets. 7:371\u2013383.", "ArticleIdList": ["16555420"]}, {"Citation": "Pratheeshkumar P, Budhraja A, Son YO, Wang X, Zhang Z, Ding S, Wang L, Hitron A, Lee JC, Xu M, et al. . 2012. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways. PloS One. 7:e47516.", "ArticleIdList": ["PMC3475699", "23094058"]}, {"Citation": "Pekamwar S, Kalyankar T, Kokate S.. 2013. Pharmacological activities of Coccinia grandis. J Appl Pharm Sci. 3:114\u2013119."}, {"Citation": "Quesada AR, Mu\u00f1oz-Ch\u00e1puli R, Medina MA.. 2006. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev. 26:483\u2013530.", "ArticleIdList": ["16652370"]}, {"Citation": "Raj MH, Yashaswini B, R\u00f6ssler J, Salimath BP.. 2016. Combinatorial treatment with anacardic acid followed by TRAIL augments induction of apoptosis in TRAIL resistant cancer cells by the regulation of p53, MAPK and NF\u03ba\u03b2 pathways. Apoptosis. 21:578\u2013593.", "ArticleIdList": ["26921178"]}, {"Citation": "Ramachandra S, D'Souza SS, Gururaj AE, Shaila MS, Salimath BP.. 2009. Paracrine action of sFLT-1 secreted by stably-transfected Ehrlich ascites tumor cells and therapy using sFLT-1 inhibits ascites tumor growth in vivo. J Gene Med. 11:422\u2013434.", "ArticleIdList": ["19266483"]}, {"Citation": "Ribatti D, Finato N, Crivellato E, Marzullo A, Mangieri D, Nico B, Vacca A, Beltrami CA.. 2005. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol. 193:1961\u20131965.", "ArticleIdList": ["16325597"]}, {"Citation": "Roy M, Chakraborty S, Siddiqi M, Bhattacharya RK.. 2002. Induction of apoptosis in tumor cells by natural phenolic compounds. Asian Pac J Cancer Prev. 3:61\u201367.", "ArticleIdList": ["12718610"]}, {"Citation": "Shivakumar S, Prabhakar BT, Jayashree K, Rajan MGR, Salimath BP.. 2009. Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast. J Cancer Res Clin Oncol. 135:627\u2013636.", "ArticleIdList": ["18936974"]}, {"Citation": "Steeg PS.2006. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 12:895\u2013904.", "ArticleIdList": ["16892035"]}, {"Citation": "Sun Q, Heilmann J, K\u00f6nig B.. 2015. Natural phenolic metabolites with anti-angiogenic properties \u2013 a review from the chemical point of view. Beilstein J Org Chem. 11:249\u2013264.", "ArticleIdList": ["PMC4361970", "25815077"]}, {"Citation": "Wagner H, Bladt S. 1996. Plant drug analysis: a thin layer chromatography atlas. Peabody, MA: Hendrickson Publishers."}, {"Citation": "Wang S, Zheng Z, Weng Y, Yu Y, Zhang D, Fan W, Dai R, Hu Z.. 2004. Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sci. 74:2467\u20132478.", "ArticleIdList": ["15010258"]}, {"Citation": "Wang W, McKinnie SM, Patel VB, Haddad G, Wang Z, Zhabyeyev P, Das SK, Basu R, McLean B, Kandalam V, et al. . 2013. Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogs. J Am Heart Assoc. 2:e000249.", "ArticleIdList": ["PMC3828798", "23817469"]}, {"Citation": "Wu WB, Hung DK, Chang FW, Ong ET, Chen BH.. 2012. Anti-inflammatory and anti-angiogenic effects of flavonoids isolated from Lycium barbarum Linnaeus on human umbilical vein endothelial cells. Food Funct. 3:1068\u20131081.", "ArticleIdList": ["22751795"]}, {"Citation": "Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ.. 2009. Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat 115:325\u2013333.", "ArticleIdList": ["18563552"]}, {"Citation": "Yu ST, Chen TM, Chern JW, Tseng SY, Chen YH.. 2009. Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis. Anticancer Drugs. 20:382\u2013388.", "ArticleIdList": ["19318911"]}]}], "History": [{"Year": "2017", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "3"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28367666", "PMC6130448", "10.1080/13880209.2017.1307422"]}}]}